---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-028691"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T16:47:59.649630+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences prices $200M public offering of common stock and pre-funded warrants

## Summary
- Priced public offering of 35.7M shares at $4.03/share and pre-funded warrants for 13.9M shares at $4.029 each; gross proceeds ~$200M.
- Net proceeds estimated at $187.5M after underwriting discounts and expenses; offering expected to close Feb 19, 2025.
- Investors include Adage Capital Partners, Bain Capital Life Sciences, Invus, Perceptive Advisors, RA Capital Management, others.
- Jefferies, Leerink Partners, William Blair act as joint book-runners; H.C. Wainwright as lead manager.

## SEC filing metadata
- accession: 0001193125-25-028691
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312525028691/0001193125-25-028691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312525028691/d908068d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-028691
- JSON: https://secwatch.observer/filing/0001193125-25-028691.json
- Plain text: https://secwatch.observer/filing/0001193125-25-028691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.